3 Small-Cap Biotech Stocks That Could Be Big Winners in 2018
Small-cap biotech stocks, or companies with valuations ranging from $300 million to $2 billion, can generate truly astonishing returns on capital in exceptionally short periods of time. Several of the best-performing biotech stocks within the past few years, after all, started off as under-the-radar companies with exceedingly low market capitalizations.
That being said, small-cap biotechs can also be tremendously risky assets to own, given that these types of companies tend to be either working on unproven technologies or still in the initial stages of a commercial launch for a key new product.
Image source: Getty Images.
Source: Fool.com
Amarin Corp. ADR Stock
€0.81
-0.610%
With 1 Buy predictions and 2 Sell predictions the community is currently undecided on Amarin Corp. ADR.
